AKASA

AKASA provides generative AI solutions tailored for the healthcare revenue cycle, helping health systems speed up processing from prior authorization through CDI, coding, and claims management. The company combines clinical and financial data to power its GenAI-powered platform and solutions, aiming to reduce denials, improve margins, and increase revenue. Its client base spans 650+ hospitals and 6,500+ outpatient facilities across all 50 states, reflecting a strong focus on US healthcare providers. AKASA positions itself as a leading provider of GenAI-enabled revenue cycle optimization and advisory capabilities for health systems.